Milestone Pharmaceuticals Inc

(NASDAQ:MIST)

Latest On Milestone Pharmaceuticals Inc (MIST):

Date/Time Type Description Signal Details
2023-05-23 00:11 ESTNewsMilestone Pharmaceuticals: Worthy Of A Dart ThrowN/A
2023-05-11 22:11 ESTNewsMilestone Pharmaceuticals GAAP EPS of -$0.35 beats by $0.05, revenue of $1MN/A
2023-03-30 06:39 ESTNewsMilestone Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.5MN/A
2023-03-29 00:27 ESTNewsMilestone Pharma receives $125M financing to support etripamil developmentN/A
2022-11-10 19:58 ESTNewsMilestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5MN/A
2022-11-05 15:16 ESTNewsMilestone Pharmaceuticals: Potential NDA Submission Of Etripamil Catalyst Set For Mid-2023N/A
2022-10-30 12:18 ESTNewsMilestone Pharmaceuticals: Looking Attractive After Drop On Positive NewsN/A
2022-10-17 17:26 ESTNewsMilestone Pharma jumps 31% as late-stage trial for lead drug meets main goalN/A
2022-08-10 20:11 ESTNewsMilestone Pharmaceuticals GAAP EPS of -$0.39 misses by $0.03N/A
2022-05-12 20:15 ESTNewsMilestone Pharmaceuticals GAAP EPS of -$0.33N/A
2022-04-06 03:08 ESTNewsMilestone Pharmaceuticals (MIST) Investor Presentation - SlideshowN/A
2022-03-24 17:14 ESTNewsMilestone Pharmaceuticals GAAP EPS of -$0.40 misses by $0.04N/A
2021-11-13 00:34 ESTNewsMilestone Pharmaceuticals EPS beats by $0.04N/A
2021-03-30 09:31 ESTNewsMilestone Pharmaceuticals EPS beats by $0.18N/A
2021-03-08 08:12 ESTAnalyst RatingThe Analyst Target Price has increased from $13.25 to $14.6.Buy
2021-01-06 16:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 20:49 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 19:05 ESTNewsFirst patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVTN/A
2020-11-17 04:42 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 04:42 ESTEarnings EstimateAn EPS average of -$0.44 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-14 07:09 ESTNewsMilestone Pharmaceuticals EPS beats by $0.09N/A
2020-11-07 16:28 ESTFinancialsCompany financials have been released.Neutral
2020-10-24 04:46 ESTNewsMilestone Pharma down 18% after pricing $45M equity offeringN/A
2020-10-23 03:05 ESTNewsMilestone Pharmaceuticals launches equity offeringN/A
2020-09-26 13:23 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:30 ESTFinancialsCompany financials have been released.Neutral
2020-08-28 17:40 ESTInsider TradeLorenz Muller has directly acquired 5,700 shares and currently holds 108,386 shares.Buy
2020-08-22 04:20 ESTNewsMilestone Pharma launches 6.7M-share secondary offeringN/A
2020-08-14 17:10 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:27 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 20:23 ESTNewsMilestone Pharmaceuticals EPS misses by $0.06N/A
2020-07-31 09:29 ESTAnalyst RatingThe Analyst Target Price has increased from $11.67 to $13.25.Buy
2020-07-31 01:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 19:54 ESTInsider TradeDE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS has directly disposed of 500,000 shares and currently holds 2,254,920 shares.Sell
2020-07-30 19:54 ESTInsider TradeDE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS has directly disposed of 19,863 shares and currently holds 2,754,920 shares.Sell
2020-07-29 05:16 ESTAnalyst RatingThe Analyst Target Price has increased from $7.67 to $11.67.Buy
2020-07-24 06:22 ESTNewsMilestone Pharma provides update on late stage etripamil study; secures $25M in equityN/A
2020-07-24 05:07 ESTAnalyst RatingThe Analyst Target Price has increased from $4 to $7.67.Neutral
2020-07-23 17:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:21 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:20 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:25 ESTFinancialsCompany financials have been released.Neutral
2020-06-10 06:50 ESTNewsMilestone Pharmaceuticals cuts salaries to reduce expensesN/A
2020-06-08 19:25 ESTInsider TradeLorenz Muller has directly acquired 18,043 shares and currently holds 102,686 shares.Buy
2020-06-08 19:25 ESTInsider TradeLorenz Muller has directly acquired 32,528 shares and currently holds 84,643 shares.Buy
2020-06-08 19:25 ESTInsider TradeLorenz Muller has directly acquired 2,500 shares and currently holds 52,115 shares.Buy
2020-06-08 19:25 ESTInsider TradeJoseph Oliveto has directly acquired 7,400 shares and currently holds 280,555 shares.Buy
2020-06-02 17:21 ESTEarnings EstimateAn EPS average of -$0.40 is estimated for the quarter ending on September 30, 2020.Buy
2020-05-27 05:31 ESTFinancialsCompany financials have been released.Neutral
2020-05-20 13:17 ESTFinancialsCompany financials have been released.Neutral

About Milestone Pharmaceuticals Inc (MIST):

Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada.

MIST Quotes by TradingView

See Advanced Chart

General

  • Name Milestone Pharmaceuticals Inc
  • Symbol MIST
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 28
  • Fiscal Year EndDecember
  • IPO Date2019-05-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Web URLhttp://www.milestonepharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.1
  • Enterprise Value EBITDA 0.3
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.52
  • Return on Assets -30%
  • Return on Equity -51%
  • Earnings Per Share -$10.84
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 218.01 million
  • EBITDA -41145000
  • PE Ratio -1.27
  • Analyst Target Price $14.6
  • Book Value Per Share $4.13
View More

Share Statistics

  • Shares Outstanding 29.82 million
  • Shares Float 11.04 million
  • % Held by Insiders 956%
  • % Held by Institutions 70.1%
  • Shares Short 252880
  • Shares Short Prior Month 236294
  • Short Ratio 2.23
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • 52 Week High $16.98
  • 52 Week Low $1.69
  • 50 Day Moving Average 7.66
  • 200 Day Moving Average 7.19
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Milestone Pharmaceuticals Inc (MIST) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Milestone Pharmaceuticals Inc (MIST) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-13$N/A-$0.40-$0.4612.42%
2020-06-302020-08-12$N/A-$0.53-$0.43-22.32%
2020-03-312020-05-14$N/A-$0.67-$0.749.76%
2019-12-312020-03-06$N/A-$0.75-$0.59-27.12%
2019-09-302019-11-13$N/A-$0.52-$0.554.59%
2019-06-302019-08-13$N/A-$0.56-$0.560.45%
2019-03-312019-05-09$N/A-$0.44

Milestone Pharmaceuticals Inc (MIST) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 8.23 million 8.62 million 11.87 million 14.15 million 9.55 million
Income Before Tax -12 million -12.98 million -16.34 million -18.29 million -12.9 million
Selling General Administrative 3.86 million 4.48 million 4.89 million 4.74 million 4.18 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -12.06 million -13.08 million -16.73 million -18.89 million -13.73 million
Operating Income -12.09 million -13.11 million -16.76 million -18.89 million -13.73 million
Income Tax Expense N/A N/A N/A N/A -73000
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A 604000 821000
Net Income From Continuing Operations -11.98 million -12.98 million -16.34 million -18.29 million -12.83 million
Net Income Applicable to Common Shares N/A -12.98 million N/A -18.29 million -12.83 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -24 million N/A N/A N/A 5 million
Change to Liabilities N/A -336000 N/A N/A 2.92 million
Total Cash Flow from Investing Activities N/A -32 million N/A N/A 4.71 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 24.82 million 172000 77000 N/A -731000
Change to Operating Activities N/A -4.4 million N/A N/A 1.41 million
Change in Cash -6.52 million -48.39 million -18 million N/A -4.32 million
Total Cash from Operating Activities N/A -16.56 million -18.08 million N/A -8.3 million
Depreciation 23000 25000 24000 N/A -69000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A -159000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A 1.19 million N/A N/A 429000
Capital Expenditures N/A N/A N/A N/A 294000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A 5.12 million 5.52 million 8.51 million 9.06 million
Total Stockholder Equity N/A 88.02 million 99.63 million 114.92 million 132.83 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets 108.8 million 93.14 million 105.16 million 123.43 million 141.89 million
Common Stock N/A 226.68 million N/A 226.25 million 226.21 million
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -154.8 million -142.82 million -129.84 million -113.5 million -95.21 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets N/A N/A N/A N/A N/A
Cash 46.91 million 53.43 million 101.82 million 119.82 million 106.5 million
Total Current Liabilities 5.88 million 4.99 million 5.37 million 8.33 million 8.84 million
Other Stockholder Equity N/A -1.63 million N/A -1.63 million -1.63 million
Property, Plant & Equipment N/A 733000 N/A 929000 921000
Total Current Assets N/A 92.41 million 104.32 million 122.5 million 140.97 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets N/A 88.02 million N/A 114.92 million 132.83 million
Short Term Investments N/A 32 million N/A N/A 30 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable N/A 2.2 million 2.23 million 8 million 8.48 million

Milestone Pharmaceuticals Inc (MIST) Chart:

Milestone Pharmaceuticals Inc (MIST) News:

Below you will find a list of latest news for Milestone Pharmaceuticals Inc (MIST) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Milestone Pharmaceuticals Inc (MIST) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-12-202.50.1CALL45 77116.52FALSE0.051
2024-12-2050.45CALL0 10FALSE00
2024-12-207.50CALL0 00FALSE00
2024-12-202.50PUT0 0125.09TRUE00
2024-12-2050PUT0 0209.27TRUE00
2024-12-207.50PUT0 00TRUE00
2025-03-212.50.3CALL0 2590FALSE00
2025-03-2150.05CALL0 320FALSE00
2025-03-217.50CALL0 00FALSE00
2025-03-212.50PUT0 096.87TRUE00
2025-03-2150PUT0 0133.61TRUE00
2025-03-217.50PUT0 00TRUE00

Latest MIST Trades:

Date Shares Price
Jun 13, 2022 4:29 PM EST100$5.32
Jun 13, 2022 6:58 PM EST100$5.34
Jun 13, 2022 6:59 PM EST100$5.3
Jun 13, 2022 6:59 PM EST100$5.28
Jun 13, 2022 6:59 PM EST100$5.28

Milestone Pharmaceuticals Inc (MIST) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-19S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1408443/000110465920075294/0001104659-20-075294-index.htm
2019-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1408443/000000000019001741/0000000000-19-001741-index.htm
2019-03-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1408443/000000000019004204/0000000000-19-004204-index.htm
2019-03-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1408443/000000000019005378/0000000000-19-005378-index.htm
2020-06-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1408443/000000000020005709/0000000000-20-005709-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000008025520001377/0000080255-20-001377-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000089924319012705/0000899243-19-012705-index.htm
2020-01-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000090445420000018/0000904454-20-000018-index.htm
2018-12-21DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1408443/000091205718000539/0000912057-18-000539-index.htm
2019-02-28DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1408443/000091205719000067/0000912057-19-000067-index.htm
2019-03-15DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1408443/000091205719000090/0000912057-19-000090-index.htm
2019-03-15DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1408443/000091205719000091/0000912057-19-000091-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000093041319001606/0000930413-19-001606-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000093041319001627/0000930413-19-001627-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000095014219001031/0000950142-19-001031-index.htm
2019-05-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000095014219001097/0000950142-19-001097-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000095014219001098/0000950142-19-001098-index.htm
2020-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000095014220001849/0000950142-20-001849-index.htm
2019-04-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1408443/000104746919002213/0001047469-19-002213-index.htm
2019-04-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1408443/000104746919002654/0001047469-19-002654-index.htm
2019-05-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1408443/000104746919002987/0001047469-19-002987-index.htm
2020-05-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1408443/000104746920002807/0001047469-20-002807-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1408443/000110465919021140/0001104659-19-021140-index.htm
2019-04-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1408443/000110465919022631/0001104659-19-022631-index.htm
2019-05-068-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1408443/000110465919027182/0001104659-19-027182-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1408443/000110465919027185/0001104659-19-027185-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1408443/000110465919027188/0001104659-19-027188-index.htm
2019-05-08S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1408443/000110465919027923/0001104659-19-027923-index.htm
2019-05-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1408443/000110465919028279/0001104659-19-028279-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919029792/0001104659-19-029792-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919031817/0001104659-19-031817-index.htm
2019-06-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1408443/000110465919036365/0001104659-19-036365-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919045417/0001104659-19-045417-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1408443/000110465919045420/0001104659-19-045420-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919049436/0001104659-19-049436-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919050788/0001104659-19-050788-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919053872/0001104659-19-053872-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919062926/0001104659-19-062926-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919069582/0001104659-19-069582-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465919073412/0001104659-19-073412-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000110465920021722/0001104659-20-021722-index.htm
2020-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1408443/000110465920030259/0001104659-20-030259-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465920037367/0001104659-20-037367-index.htm
2020-04-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000110465920043073/0001104659-20-043073-index.htm
2020-05-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1408443/000110465920056974/0001104659-20-056974-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465920070959/0001104659-20-070959-index.htm
2020-06-19S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1408443/000110465920075294/0001104659-20-075294-index.htm
2020-07-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1408443/000110465920079777/0001104659-20-079777-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465920085814/0001104659-20-085814-index.htm
2020-07-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1408443/000110465920087527/0001104659-20-087527-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465920087533/0001104659-20-087533-index.htm
2020-08-20S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1408443/000110465920097218/0001104659-20-097218-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465920107173/0001104659-20-107173-index.htm
2020-10-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1408443/000110465920117164/0001104659-20-117164-index.htm
2020-10-22S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1408443/000110465920117347/0001104659-20-117347-index.htm
2020-10-2310-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1408443/000110465920117701/0001104659-20-117701-index.htm
2020-10-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1408443/000110465920118159/0001104659-20-118159-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1408443/000110465920118163/0001104659-20-118163-index.htm
2015-06-15DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000114420415037254/0001144204-15-037254-index.htm
2019-05-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1408443/000119312519146584/0001193125-19-146584-index.htm
2019-09-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1408443/000119312519250305/0001193125-19-250305-index.htm
2019-11-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1408443/000119312519302384/0001193125-19-302384-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000119312520031486/0001193125-20-031486-index.htm
2020-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1408443/000119312520071333/0001193125-20-071333-index.htm
2020-08-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000119312520208100/0001193125-20-208100-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028362/0001209191-19-028362-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028363/0001209191-19-028363-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028364/0001209191-19-028364-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028365/0001209191-19-028365-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028367/0001209191-19-028367-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028369/0001209191-19-028369-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028370/0001209191-19-028370-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028371/0001209191-19-028371-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028373/0001209191-19-028373-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028375/0001209191-19-028375-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028377/0001209191-19-028377-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119028517/0001209191-19-028517-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119029660/0001209191-19-029660-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119029668/0001209191-19-029668-index.htm
2019-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119049208/0001209191-19-049208-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119049210/0001209191-19-049210-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119049211/0001209191-19-049211-index.htm
2019-11-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119056622/0001209191-19-056622-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119056624/0001209191-19-056624-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119056625/0001209191-19-056625-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119056626/0001209191-19-056626-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919119058290/0001209191-19-058290-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120004895/0001209191-20-004895-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120004899/0001209191-20-004899-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120004901/0001209191-20-004901-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120004903/0001209191-20-004903-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/0001209191-20-035110-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035111/0001209191-20-035111-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035113/0001209191-20-035113-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035114/0001209191-20-035114-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035116/0001209191-20-035116-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035117/0001209191-20-035117-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035119/0001209191-20-035119-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035120/0001209191-20-035120-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120035129/0001209191-20-035129-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120048651/0001209191-20-048651-index.htm
2020-10-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120053833/0001209191-20-053833-index.htm
2020-10-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120053836/0001209191-20-053836-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120053839/0001209191-20-053839-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000120919120053842/0001209191-20-053842-index.htm
2019-05-07CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1408443/000135445719000257/0001354457-19-000257-index.htm
2011-06-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000140844311000004/0001408443-11-000004-index.htm
2017-07-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000140844317000002/0001408443-17-000002-index.htm
2018-10-26DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000140844318000001/0001408443-18-000001-index.htm
2019-02-27DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1408443/000141057819000104/0001410578-19-000104-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315219006595/0001493152-19-006595-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315219006679/0001493152-19-006679-index.htm
2019-05-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000149315219007825/0001493152-19-007825-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315219014959/0001493152-19-014959-index.htm
2019-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315219015513/0001493152-19-015513-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315219018241/0001493152-19-018241-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220000046/0001493152-20-000046-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220000524/0001493152-20-000524-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220002407/0001493152-20-002407-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220004347/0001493152-20-004347-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220004365/0001493152-20-004365-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220013937/0001493152-20-013937-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1408443/000149315220020101/0001493152-20-020101-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1408443/000155837019010889/0001558370-19-010889-index.htm
2020-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1408443/000155837020002106/0001558370-20-002106-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1408443/000155837020006548/0001558370-20-006548-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1408443/000155837020010374/0001558370-20-010374-index.htm
2019-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1408443/999999999519001048/9999999995-19-001048-index.htm
2020-07-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1408443/999999999520001653/9999999995-20-001653-index.htm
2007-07-30REGDEXNotice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]https://www.sec.gov/Archives/edgar/data/1408443/999999999707035521/9999999997-07-035521-index.htm

Milestone Pharmaceuticals Inc (MIST) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Milestone Pharmaceuticals Inc (MIST). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 956%
Institutional Ownership: 7010%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-04-03Lorenz MullerChief Commercial OfficerBuy18,043.001.5427,786.22102,686.00https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/0001209191-20-035110-index.htm
2020-08-26Lorenz MullerChief Commercial OfficerBuy5,700.001.548,778.00108,386.00https://www.sec.gov/Archives/edgar/data/1408443/000120919120048651/0001209191-20-048651-index.htm
2019-05-13Holdings A/S Novo10% Share HolderBuy1,377,048.001,377,048.00https://www.sec.gov/Archives/edgar/data/1408443/000120919119029660/0001209191-19-029660-index.htm
2020-07-29DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS10% Share HolderSell500,000.008.324,160,000.002,254,920.00https://www.sec.gov/Archives/edgar/data/1408443/000095014220001849/0000950142-20-001849-index.htm
2019-05-13Holdings A/S Novo10% Share HolderBuy964,089.002,341,137.00https://www.sec.gov/Archives/edgar/data/1408443/000120919119029660/0001209191-19-029660-index.htm
2019-05-08BDC CAPITAL INC.10% Share HolderBuy200,000.0015.003,000,000.002,388,088.00https://www.sec.gov/Archives/edgar/data/1408443/000093041319001627/0000930413-19-001627-index.htm
2019-11-25Holdings A/S Novo10% Share HolderSell240,000.0016.003,840,000.002,434,470.00https://www.sec.gov/Archives/edgar/data/1408443/000120919119058290/0001209191-19-058290-index.htm
2019-05-13Holdings A/S Novo10% Share HolderBuy333,333.0015.004,999,995.002,674,470.00https://www.sec.gov/Archives/edgar/data/1408443/000120919119029660/0001209191-19-029660-index.htm
2019-05-13DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS10% Share HolderBuy433,333.0015.006,499,995.002,720,310.00https://www.sec.gov/Archives/edgar/data/1408443/000095014219001098/0000950142-19-001098-index.htm
2020-07-28DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS10% Share HolderSell19,863.008.10160,890.302,754,920.00https://www.sec.gov/Archives/edgar/data/1408443/000095014220001849/0000950142-20-001849-index.htm
2019-12-21Joseph OlivetoPresident and CEOBuy7,400.001.5411,396.00280,555.00https://www.sec.gov/Archives/edgar/data/1408443/000120919120035116/0001209191-20-035116-index.htm
2019-05-09RTW INVESTMENTS, LP10% Share HolderBuy666,667.0015.0010,000,005.003,521,856.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219006679/0001493152-19-006679-index.htm
2019-10-01RTW INVESTMENTS, LP10% Share HolderBuy6,242.0017.63110,038.973,528,098.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219014959/0001493152-19-014959-index.htm
2019-10-03RTW INVESTMENTS, LP10% Share HolderBuy1,908.0018.3134,939.873,530,006.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219014959/0001493152-19-014959-index.htm
2019-10-10RTW INVESTMENTS, LP10% Share HolderBuy179.0016.002,864.003,530,185.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219015513/0001493152-19-015513-index.htm
2019-10-11RTW INVESTMENTS, LP10% Share HolderBuy4,208.0017.3072,790.833,534,393.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219015513/0001493152-19-015513-index.htm
2019-10-15RTW INVESTMENTS, LP10% Share HolderBuy1,100.0018.0019,800.003,535,493.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219015513/0001493152-19-015513-index.htm
2019-11-20RTW INVESTMENTS, LP10% Share HolderBuy400,000.0016.006,400,000.003,935,493.00https://www.sec.gov/Archives/edgar/data/1408443/000149315219018241/0001493152-19-018241-index.htm
2019-12-30RTW INVESTMENTS, LP10% Share HolderBuy1,333.0015.4820,637.773,936,826.00https://www.sec.gov/Archives/edgar/data/1408443/000149315220000046/0001493152-20-000046-index.htm
2019-12-31RTW INVESTMENTS, LP10% Share HolderBuy21,438.0015.50332,340.453,958,264.00https://www.sec.gov/Archives/edgar/data/1408443/000149315220000046/0001493152-20-000046-index.htm
2020-01-13RTW INVESTMENTS, LP10% Share HolderBuy270,000.0016.254,387,500.004,228,264.00https://www.sec.gov/Archives/edgar/data/1408443/000149315220000524/0001493152-20-000524-index.htm
2020-03-02RTW INVESTMENTS, LP10% Share HolderBuy78,263.0018.951,483,083.854,306,527.00https://www.sec.gov/Archives/edgar/data/1408443/000149315220004347/0001493152-20-004347-index.htm
2020-03-18RTW INVESTMENTS, LP10% Share HolderBuy2,705.0010.3628,028.674,309,232.00https://www.sec.gov/Archives/edgar/data/1408443/000149315220004365/0001493152-20-004365-index.htm
2020-03-19RTW INVESTMENTS, LP10% Share HolderBuy5,870.0010.8763,803.974,315,102.00https://www.sec.gov/Archives/edgar/data/1408443/000149315220004365/0001493152-20-004365-index.htm
2019-10-01Lorenz MullerChief Commercial OfficerBuy2,500.001.543,850.0052,115.00https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/0001209191-20-035110-index.htm
2020-04-03Lorenz MullerChief Commercial OfficerBuy32,528.001.5450,093.1284,643.00https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/0001209191-20-035110-index.htm